New ASM President and Leadership Begin Their Terms
July 1, 2026
Washington, D.C.-ASM welcomes a new president, president-elect and member of the
ASM Board of Directors, who will begin their leadership terms on July 1, 2026. Together, these leaders will help advance ASM's mission and guide the continued evolution of its 3 scientific units.
Vaughn Cooper, Ph.D., professor of microbiology and molecular genetics and computational and systems biology at the University of Pittsburgh School of Medicine and Co-Founder and Director of the Center for Evolutionary Biology and Medicine, will serve as President of the Board of Directors.
Federico Sisti, Ph.D., an independent researcher at the Institute of Biotechnology and Molecular Biology (IBBM) of the National Scientific and Technical Research Council (CONICET), will serve as President-Elect of the Board of Directors.
Yvette S. McCarter, Ph.D., D(ABMM), has also been appointed by the ASM Board of Directors, in accordance with ASM Bylaws, to serve the remainder of Sisti's term as At-Large Board Director, which concludes on June 30, 2026.
ASM congratulates its new and continuing leaders and looks forward to their leadership in advancing the microbial sciences and ASM's strategic priorities.
###
ASM is a global community shaping the future of the microbial sciences to tackle some of the world's most pressing challenges. Established in 1899, ASM connects scientists across disciplines, sectors and borders to advance discovery, foster collaboration and drive innovation.
With more than 38,000 members and a global network that reaches millions, ASM accelerates scientific progress through publishing, convening, advocacy and professional development. From climate change and antimicrobial resistance to industrial, basic and applied microbiology, ASM empowers the microbial sciences community to create solutions that benefit society and build what's next.